跳至主要内容
临床试验/ISRCTN26092132
ISRCTN26092132已完成未知

Metformin improves Endothelial function, endothelial progenitor cells and cardiovascular Risk factors In Type 1 diabetes (MERIT study)

Gateshead Health NHS Foundation Trust (UK)0 个研究点目标入组 46 人开始时间: 2012年7月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Type 1 diabetes mellitus
  • 2. Aged 16 years or over
  • 3. HbA1c <= 8.5
  • 4. Duration of diabetes of at least 5 years
  • 5. Stable diabetes control for at least 2 months

排除标准

  • 1. Glomerular filtration rate (GFR) < 45 ml/ min/ 1.73m2
  • 2. Woman of childbearing age planning pregnancy
  • 3. Pregnancy and/or lactation
  • 4. Proliferative diabetic retinopathy
  • 5. Cardiovascular disease/ischemic heart disease (IHD)
  • 6. Peripheral vascular disease
  • 7. Cerebrovascular accident (CVA) or transient ischemic attack (TIA)
  • 8. Suspected hypoglycaemia unawareness
  • 9. Impaired cognitive function/ unable to give informed consent
  • 10. History of lactic acidosis
  • 11. Contraindications to metformin
  • 12. History of alcohol problem or drug abuse

研究者

发起方
Gateshead Health NHS Foundation Trust (UK)

相似试验